Description
MERS-CoV virus stock is produced by cell culture and formulated with purified, intact viral particles. The virus particles have been inactivated to render them non-infectious and refrigerator stable. The inactivation was verified in a standard microbiological growth protocol. MERS-CoV stock can be used in the development of MERS-CoV diagnostics and in vaccine development and R&D.